Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jan
11
2017
Florida Board of Medicine Hearing on Telemedicine and Medical Marijuana Squire Patton Boggs (US) LLP
Nov
12
2020
Brexit: Phased Approach for Northern Ireland Protocol (NIP) for the Pharmaceuticals Sector Squire Patton Boggs (US) LLP
Dec
3
2020
EU’s New Pharmaceutical Strategy Squire Patton Boggs (US) LLP
May
9
2017
Does Southern Hemisphere Rugby Have A Recreational Drug Problem? Squire Patton Boggs (US) LLP
Jan
1
2021
Federal Circuit Endorses the Doctrine of Equivalents Again for Lilly’s ALIMTA®: Different Amendment, Same Result Squire Patton Boggs (US) LLP
May
22
2017
FDA User Fee Reauthorization Moves to Full Committee; HHS Further Delays Bundled Payment Models and Changes to 340B Drug Discount Program Squire Patton Boggs (US) LLP
Dec
20
2017
FDA Issues Guidance on Clinical and Patient Decision Support Software Squire Patton Boggs (US) LLP
Nov
29
2021
Judge Blocks Portions of Centers for Medicare and Medicaid Services (CMS) Vaccine Mandate (US) Squire Patton Boggs (US) LLP
Jan
31
2023
Bankruptcy Court Doors Swing Open For Cannabis Companies, But Just Slightly Squire Patton Boggs (US) LLP
Mar
19
2020
Can Coverage for COVID-19 Be Excluded? Squire Patton Boggs (US) LLP
Oct
4
2023
Key Areas of Focus in U.S.-China Relations and Their Impact on Businesses in the 118th Congress Squire Patton Boggs (US) LLP
Nov
22
2023
FDA Delays Enforcement of MOCRA Deadlines for Facility Registration and Product Listing to July 1, 2024 Squire Patton Boggs (US) LLP
Nov
11
2016
Recreational Marijuana Use Legalized in Four States, But Employers’ Ability to Enforce Workplace Drug Policies Undisturbed Squire Patton Boggs (US) LLP
Jul
14
2020
The Bio/Pharma Beat July 2020 Squire Patton Boggs (US) LLP
Jul
24
2020
Sixth Circuit Panel Dismisses Motion to Enforce Writ of Mandamus Squire Patton Boggs (US) LLP
Nov
6
2020
Election 2020 Puts Cannabis Center Stage Squire Patton Boggs (US) LLP
May
7
2024
Navigating the Regulatory Maze: Hemp Industry Calls for Additional Federal Action Squire Patton Boggs (US) LLP
Jan
2
2021
Twelve Cannabis Plant Patents and Counting Squire Patton Boggs (US) LLP
Jan
24
2018
Here’s a Nug of Information: California Is Now Accepting Cannabis-Related Trademarks Squire Patton Boggs (US) LLP
Feb
22
2018
Is the Restaurant Trade “Dining Out”? Squire Patton Boggs (US) LLP
Mar
12
2018
An analysis of the DCMS Select Committee Report: ‘Combatting doping in sport’ – Part 3 – ‘UK Athletics’ and ‘Criminalisation of doping in sports’ Squire Patton Boggs (US) LLP
Jan
18
2022
US Federal Labor Viewpoints – Week of January 10, 2022 Squire Patton Boggs (US) LLP
Jun
14
2019
That Didn’t Take Long: Ninth Circuit’s Decision in Garvin v. Cook Invs. NW is Challenged Squire Patton Boggs (US) LLP
Mar
16
2015
House And Senate Committees To Mark Up Budget Resolutions; How Will Congress Deal With The Sequester; Debt Limit Reached Squire Patton Boggs (US) LLP
Jan
4
2023
IDR Payment Disputes are Far Outpacing Projections, Creating Backlogs Squire Patton Boggs (US) LLP
Oct
10
2019
Opioid Update: Sixth Circuit Won’t Halt Bellwether Trial (and more) Squire Patton Boggs (US) LLP
Oct
20
2015
The Federal Circuit Declines To Revisit Its Decision That The Biosimilars Patent Dance Is Optional – Next Stop, Supreme Court? Squire Patton Boggs (US) LLP
Nov
2
2015
Food Supply Chain Issues in China (Or, China’s New Food Safety Act) (Or, Running the Gauntlet in China) Squire Patton Boggs (US) LLP
Feb
3
2020
Opioid Update: MDL Defendants Return to the Sixth Circuit Squire Patton Boggs (US) LLP
Aug
15
2023
How Close Can You Be to Cannabis and Still Have Access to the Bankruptcy Courts? (US) Squire Patton Boggs (US) LLP
Apr
14
2020
The Open COVID Pledge: What Is It and Is It Right for You? Squire Patton Boggs (US) LLP
Apr
30
2020
Global Supply Chains In The Wake Of COVID-19 In Socially Critical Industries – Is It Time To Reshore? Squire Patton Boggs (US) LLP
Dec
12
2016
Improper Marketing of Abilify, DOJ and Internet Gambling: State Attorneys General December 12 Update Squire Patton Boggs (US) LLP
Sep
25
2020
Prop 65 Victory For Chemical Industry In Monsanto Case Has Been Appealed Squire Patton Boggs (US) LLP
Jun
5
2017
International Food Assistance Programs in the Farm Bill Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins